Compare NQP & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NQP | CLPT |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.1M | 494.6M |
| IPO Year | N/A | N/A |
| Metric | NQP | CLPT |
|---|---|---|
| Price | $11.88 | $15.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | 58.4K | ★ 660.7K |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,332,000.00 |
| Revenue This Year | N/A | $18.93 |
| Revenue Next Year | N/A | $51.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $9.65 | $9.76 |
| 52 Week High | $11.89 | $30.10 |
| Indicator | NQP | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 57.50 |
| Support Level | $11.83 | $13.51 |
| Resistance Level | $12.10 | $16.58 |
| Average True Range (ATR) | 0.07 | 1.13 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 15.52 | 71.99 |
Nuveen Pennsylvania Quality Municipal Income Fund is a closed-end fixed income mutual fund. The fund's investment objectives are (i) to provide current income exempt from regular federal income tax, the federal alternative minimum tax applicable to individuals and California income tax and (ii) to enhance portfolio value relative to the municipal bond market by investing in tax- exempt municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser, believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund prominenty invests in tax-exempt municipal bonds from Pennsylvania that are investment grade.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.